Results 41 to 50 of about 1,158,489 (305)

Gut microbiome and aging—A dynamic interplay of microbes, metabolites, and the immune system

open access: yesFEBS Letters, EarlyView.
Age‐dependent shifts in microbial communities engender shifts in microbial metabolite profiles. These in turn drive shifts in barrier surface permeability of the gut and brain and induce immune activation. When paired with preexisting age‐related chronic inflammation this increases the risk of neuroinflammation and neurodegenerative diseases.
Aaron Mehl, Eran Blacher
wiley   +1 more source

Microbiome−host proteostasis crosstalk—An emerging perspective on mechanisms and interventions toward healthy longevity

open access: yesFEBS Letters, EarlyView.
Proteostasis and the gut microbiota play a key role in shaping host physiology. Microbiota‐derived metabolites, vitamins, and RNA modulate host proteostasis. Findings from model systems, including C. elegans, indicate microbes can either stabilize or disrupt host proteostasis.
Abhishek Anil Dubey, Maria Ermolaeva
wiley   +1 more source

Adaptive immunity shapes baseline physiology of M. tuberculosis in high-dose versus low-dose infection BALB/c mouse drug treatment models

open access: yesAntimicrobial Agents and Chemotherapy
Preclinical tuberculosis (TB) drug evaluation relies heavily on mouse infection models. Drug efficacy varies depending on inoculum and the timing of treatment initiation.
Jo Hendrix   +11 more
doaj   +1 more source

Biodegradation of hydrocarbons in soil by microbial consortium [PDF]

open access: yesInternational Biodeterioration & Biodegradation, 2004
The bioremediation of hydrocarbon in contaminated soils by mixed cultures of hydrocarbon-degrading bacteria was investigated. The mixtures or consortia of bacteria, denoted as Consortium 1 and Consortium 2 consisted of 3 and 6 bacterial strains, respectively.
Mohamad Ghazali, Farinazleen   +3 more
openaire   +1 more source

Consortium Building For PEM MFC Using Synthetic Media As Substrate [PDF]

open access: yes, 2011
Microbial production of electricity is an important form of bioenergy since Microbial Fuel cells (MFC) offer the possibility of extracting electric current from a wide range of organic wastes and renewable biomass.
Muralidharan Ayyappan   +3 more
core  

Design and analysis strategies for robust microbiome ageing research

open access: yesFEBS Letters, EarlyView.
The gut microbiome changes with age and associates with age‐related morbidity and mortality, establishing it as a potential biomarker and intervention target for ageing. Realising this potential requires methodological rigour, yet distinguishing biological signals from methodological artefacts remains challenging across cohorts. This review provides an
Mark Olenik   +5 more
wiley   +1 more source

Metagenomic analysis of microbial consortium GF-20 in corn stover degradation at low temperature

open access: yesJournal of Environmental Engineering and Landscape Management, 2023
In our previous work, a microbial consortium GF-20 (Qinggeer et al., 2016) was enriched from compost habitats and adapted to efficiently and stably degrade corn stover under low temperatures.
Bi-zhou Zhang   +7 more
doaj   +1 more source

EMbaRC - A European Consortium of Microbial Resource Centres for Science & lnnovation [PDF]

open access: yes, 2010
EMbaRC is an EU project funded under the Seventh Framework Programme, Research lnfrastructures action. lt aims to improve, coordinate and validate microbial Biological Resource Centres (BRC) delivery to European and lnternational researchers from both ...
Lortal, Sylvie   +11 more
core  

Raw sequencing data of enriched microbial consortium

open access: yes, 2023
 Raw sequencing data of enriched microbial consortium  
srisuda chaikitkaew (10163456)
core   +1 more source

From Adult to Adolescent: Alignment in Clinical Trials and Outcomes in Axial Spondyloarthritis

open access: yesArthritis Care &Research, EarlyView.
Spondyloarthritis (SpA) is a group of chronic inflammatory diseases encompassing axial and peripheral forms, with up to 20% of patients developing symptoms before age 16. Despite this substantial pediatric burden, treatment options for juvenile‐onset SpA (JSpA), particularly those with axial disease (axJSpA), remain limited.
Pamela F. Weiss   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy